Development and evaluation of pk-Ctone: A computationally efficient strategy for enhanced Mandarin tone perception in cochlear implants
The Journal of the Acoustical Society of America · 2026
DOI: 10.1121/10.0046666 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of the Acoustical Society of America, 2026. Verfasst von Yibo Lei und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Zhengzhou University (Otology), Zhengzhou 450052, China. Hauptthemen laut MEDLINE: Cochlear Implants, Speech Perception, Speech Acoustics, Cochlear Implantation. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Leading Innovative and Entrepreneur Team Introduction Program of Hangzhou, Zhejiang Key Laboratory of Intelligent Rehabilitation and Translational Neuroelectronics.
Abstract (Originalsprache)
Conventional cochlear implant (CI) strategies convey limited tonal information. Although fundamental frequency (F0)-based strategies, such as C-tone, which combines F0 extraction with amplitude envelope modulation, improve Mandarin tone perception, their high computational demands hinder integration into power- and resource-constrained devices. This study evaluates a lexical tone enhancement CI strategy, pk-Ctone, that employs a computationally efficient local extrema-based F0 detection algorithm. Acoustic evaluations on two Mandarin monosyllabic corpora assessed both the coarse-scale robustness and fine-scale fidelity of F0 detection. Computational operations required for F0 extraction were quantified, and a clinical trial with 62 participants compared Mandarin speech recognition using pk-Ctone versus a standard envelope-based baseline. Results showed that pk-Ctone reduced the computational operations for F0 extraction by more than 30-fold compared with C-tone. Although this efficiency gain incurred a penalty in fine-scale precision, pk-Ctone achieved improved coarse-scale robustness, as quantified by Accuracy and F1-score. Clinically, pk-Ctone yielded significant improvements in recognition of monosyllabic tones (+10.1% points, pp), monosyllabic words (+19.2 pp), and disyllabic words (+13.0 pp). These findings indicate that pk-Ctone, by preserving coarse-scale F0 tracking robustness while reducing computational cost, maintains clinical effectiveness despite some loss in fine-scale precision, offering a practical solution for power- and resource-constrained CI processors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The First Affiliated Hospital of Zhengzhou University (Otology), Zhengzhou 450052, China.
- Zhejiang Key Laboratory of Intelligent Rehabilitation and Translational Neuroelectronics, Hangzhou, Zhejiang 310011, China.
- Zhejiang Nurotron Biotechnology Co. Ltd., Hangzhou, Zhejiang 310011, China.
- College of Computer Science and Technology, Tongji University, Shanghai 200092, China.
Förderung
- Leading Innovative and Entrepreneur Team Introduction Program of Hangzhou
- Zhejiang Key Laboratory of Intelligent Rehabilitation and Translational Neuroelectronics
Zitieren
APA
Lei, Y., Huang, S., Chen, H., Yang, D., Liu, Q., Tan, Z., Han, T., Lu, W., & Xiang, L. (2026). Development and evaluation of pk-Ctone: A computationally efficient strategy for enhanced Mandarin tone perception in cochlear implants. The Journal of the Acoustical Society of America. https://doi.org/10.1121/10.0046666
Vancouver
Lei Y, Huang S, Chen H, Yang D, Liu Q, Tan Z, et al. Development and evaluation of pk-Ctone: A computationally efficient strategy for enhanced Mandarin tone perception in cochlear implants. The Journal of the Acoustical Society of America. 2026. doi:10.1121/10.0046666
BibTeX
@article{Lei2026,
author = {Lei, Yibo and Huang, Sui and Chen, Hongbin and Yang, Dian and Liu, Quan and Tan, Zhiping and Han, Tingxu and Lu, Wei and Xiang, Liyang},
title = {Development and evaluation of pk-Ctone: A computationally efficient strategy for enhanced Mandarin tone perception in cochlear implants},
journal = {The Journal of the Acoustical Society of America},
year = {2026},
doi = {10.1121/10.0046666}
}
EUVIMED